Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Vascular Surgery

  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 75 articles:
HTML format

Single Articles

    April 2023
  1. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    PubMed     Abstract available

    February 2023
  2. KAUL U, Arambam P, Sinha SK, Abhaichand R, et al
    Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
    Am Heart J. 2023;256:128-138.
    PubMed     Abstract available

    January 2023
  3. SPAULDING C, Krackhardt F, Bogaerts K, Urban P, et al
    Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00010-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available

  4. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available

  5. MOLLER JE, Gerke O
    Danish-German cardiogenic shock trial-DanGer shock: Trial design update.
    Am Heart J. 2023;255:90-93.
    PubMed     Abstract available

    December 2022
  6. DELEWI R, Vogel RF, Wilschut JM, Lemmert ME, et al
    Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00335-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available

  7. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available

  8. EKMEJIAN A, Allahwala U, Ward M, Bhindi R, et al
    Impact of coronary disease patterns, anatomical factors, micro-vascular disease and non-coronary cardiac factors on invasive coronary physiology.
    Am Heart J. 2022 Dec 9:S0002-8703(22)00327-1. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available

  9. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available

  10. DI X, Liu C, Ni L, Ye W, et al
    Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled, double-blind, phase III clinical trials.
    Am Heart J. 2022;254:88-101.
    PubMed     Abstract available

  11. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    PubMed     Abstract available

    November 2022
  12. RAMUNDDAL T, Holck EN, Karim S, Eftekhari A, et al
    International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions with Myocardial Ischemia - ISCHEMIA-CTO Trial - Rationale and Design.
    Am Heart J. 2022 Nov 21:S0002-8703(22)00298-8. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available

  13. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available

  14. LEE M, Ahmed ZV, Huang J, Brice A, et al
    Antiplatelet regimens following carotid artery revascularization.
    Am Heart J. 2022;253:48-52.
    PubMed     Abstract available

    October 2022
  15. GASPARDONE C, Romagnolo D, Fasolino A, Falasconi G, et al
    A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Oct 19. pii: S0002-8703(22)00272.
    PubMed     Abstract available

  16. WOLNY R, Niedziela J, Desperak P, Kwiecinski J, et al
    Infarct-related artery and long-term mortality following recurrent ST-segment elevation myocardial infarction. Insights from a Polish nationwide registry.
    Am Heart J. 2022 Oct 12. pii: S0002-8703(22)00200.
    PubMed     Abstract available

  17. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    PubMed     Abstract available

  18. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    PubMed     Abstract available

  19. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    PubMed     Abstract available

  20. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    PubMed     Abstract available

    September 2022
  21. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    PubMed     Abstract available

  22. KAPUR NK, Kim RJ, Moses JW, Stone GW, et al
    Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.
    Am Heart J. 2022 Sep 1. pii: S0002-8703(22)00184.
    PubMed     Abstract available

    August 2022
  23. SALZMANN S, Laferton JAC, Shedden-Mora MC, Horn N, et al
    Pre-surgery optimization of patients' expectations to improve outcome in heart surgery: Study protocol of the randomized controlled multi-center PSY-HEART-II trial.
    Am Heart J. 2022 Aug 5. pii: S0002-8703(22)00161.
    PubMed     Abstract available

    June 2022
  24. VOGEL RF, Delewi R, Wilschut JM, Lemmert ME, et al
    Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial.
    Am Heart J. 2022 Jun 4. pii: S0002-8703(22)00116.
    PubMed     Abstract available

    May 2022
  25. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    PubMed     Abstract available

  26. OMEROVIC E, Erlinge D, Koul S, Frobert O, et al
    Rationale and Design of Switch Swedeheart: A Registry-Based, Stepped-Wedge, Cluster-Randomized, Open-Label Multicenter Trial to Compare Prasugrel and Ticagrelor for Treatment of Patients with Acute Coronary Syndrome.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00112.
    PubMed     Abstract available

  27. CANTOR WJ, Tan M, Berwanger O, Lavi S, et al
    Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00089.
    PubMed     Abstract available

  28. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    PubMed     Abstract available

    April 2022
  29. DE OLIVEIRA MARREIROS DJ, Tomsic A, van Brakel TJ, Hamming JF, et al
    Computed tomography follow-up after elective proximal aortic surgery: less is more?
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00068.
    PubMed     Abstract available

  30. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    PubMed     Abstract available

  31. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    PubMed     Abstract available

    March 2022
  32. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
    Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
    Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
    PubMed     Abstract available

  33. GENEREUX P, Chernin G, Assali AR, Peruga JZ, et al
    Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.
    Am Heart J. 2022 Mar 16. pii: S0002-8703(22)00052.
    PubMed     Abstract available

  34. GENEREUX P, Kirtane AJ, Kandzari DE, Armstrong EJ, et al
    Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.
    Am Heart J. 2022 Mar 11. pii: S0002-8703(22)00051.
    PubMed     Abstract available

    February 2022
  35. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    PubMed     Abstract available

    January 2022
  36. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    PubMed     Abstract available

  37. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    PubMed     Abstract available

  38. HARIRI E, Kassas I, Hammoud MA, Hansra B, et al
    Same Day Discharge Following Non-elective PCI for Non-ST Elevation Acute Coronary Syndromes.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00497.
    PubMed     Abstract available

  39. HARA H, Serruys PW, O'Leary N, Gao C, et al
    Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
    PubMed     Abstract available

  40. AMIN AP, Frogge N, Kulkarni H, Ridolfi G, et al
    The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention.
    Am Heart J. 2022;243:221-231.
    PubMed     Abstract available

    December 2021
  41. SIDHU MS, Lyubarova R, Bangalore S, Bonaca MP, et al
    Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00478.
    PubMed     Abstract available

  42. PASALA S, Cooper LB, Psotka MA, Sinha SS, et al
    The Influence of Heart Failure on Clinical and Economic Outcomes among Older Adult >/=75 Years of Age with Acute Myocardial Infarction.
    Am Heart J. 2021 Dec 16. pii: S0002-8703(21)00474.
    PubMed     Abstract available

  43. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    PubMed     Abstract available

  44. MONTOY JCC, Shen YC, Krumholz HM, Hsia RY, et al
    Association of STEMI regionalization of care with de facto NSTEMI regionalization.
    Am Heart J. 2021;242:1-5.
    PubMed     Abstract available

    November 2021
  45. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    PubMed     Abstract available

  46. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    PubMed     Abstract available

  47. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
    Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
    Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
    PubMed     Abstract available

  48. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
    The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
    Am Heart J. 2021;241:92-100.
    PubMed     Abstract available

  49. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
    Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
    Am Heart J. 2021;241:101-107.
    PubMed     Abstract available

    October 2021
  50. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
    Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
    PubMed     Abstract available

    September 2021
  51. TAVENIER AH, Hermanides RS, Ottervanger JP, Belitser SV, et al
    Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: a pre-specified sub-analysis of the ON-TIME 3 trial.
    Am Heart J. 2021 Sep 18. pii: S0002-8703(21)00209.
    PubMed     Abstract available

  52. DE KONING MLY, van Dorp P, Assa S, Hartman MHT, et al
    Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after ST-segment Elevation Myocardial Infarction (GIPS-IV) Trial.
    Am Heart J. 2021 Sep 14. pii: S0002-8703(21)00210.
    PubMed     Abstract available

  53. NARCISSE DI, Ford CB, Weissler EH, Lippmann SJ, et al
    The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.
    Am Heart J. 2021;239:135-146.
    PubMed     Abstract available

    July 2021
  54. HSU B, Carcel C, Wang X, Peters SAE, et al
    Sex differences in emergency medical services management of patients with myocardial infarction: analysis of routinely collected data for over 110,000 patients.
    Am Heart J. 2021 Jul 24. pii: S0002-8703(21)00188.
    PubMed     Abstract available

    June 2021
  55. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    PubMed     Abstract available

  56. HU X, Wang Y
    Importance of complete revascularization and surgical techniques when comparing outcomes of CABG with PCI.
    Am Heart J. 2021;236:107-108.

    May 2021
  57. BAJAJ R, Parasa R, Ramasamy A, Makariou N, et al
    Computerized technologies informing cardiac catheterization and guiding coronary intervention.
    Am Heart J. 2021 May 30. pii: S0002-8703(21)00146.
    PubMed     Abstract available

  58. YERASI C, Case BC, Chezar-Azerrad C, Forrestal BJ, et al
    Cangrelor vs. Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention.
    Am Heart J. 2021 May 4. pii: S0002-8703(21)00115.
    PubMed     Abstract available

  59. MADSEN JMM, Jacobsen MRR, Sabbah M, Topal DGG, et al
    Long-Term Prognostic Outcomes and Implication of Oral Anticoagulants in Patients with New-Onset Atrial Fibrillation following ST-Segment Elevation Myocardial Infarction.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00114.
    PubMed     Abstract available

  60. SIDEBOTTOM AC, Miedema MD, Benson G, Vacquier M, et al
    The Impact of a Population-based Prevention Program on Cardiovascular Events: Findings from the Heart of New Ulm Project.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00112.
    PubMed     Abstract available

    April 2021
  61. SINGH H, Mehta RH, O'Neill W, Kapur NK, et al
    Clinical Features and Outcomes in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Early versus Recent Experience with Impella.
    Am Heart J. 2021 Apr 10. pii: S0002-8703(21)00090.
    PubMed     Abstract available

    March 2021
  62. QU J, Du J, Rao C, Chen S, et al
    Effect of a Smartphone-Based Intervention on Secondary Prevention Medication Prescriptions After Coronary Artery Bypass Graft Surgery: The MISSION-1 Randomized Controlled Trial.
    Am Heart J. 2021 Mar 6. pii: S0002-8703(21)00070.
    PubMed     Abstract available

    February 2021
  63. BATCHELOR WB, Damluji AA, Yong C, Fiuzat M, et al
    Am Heart J. 2021 Feb 23. pii: S0002-8703(21)00035.
    PubMed     Abstract available

  64. GE Z, Gao XF, Kan J, Kong XQ, et al
    Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicent
    Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00053.
    PubMed     Abstract available

  65. PILGRIM T, Rothenbuhler M, Siontis GC, Kandzari DE, et al
    Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials.
    Am Heart J. 2021 Feb 17. pii: S0002-8703(21)00048.
    PubMed     Abstract available

  66. PRABHU KM, Don C, Sayre GG, Kearney KE, et al
    Interventional Cardiologists' Perceptions of Percutaneous Coronary Intervention Quality Measurement and Feedback.
    Am Heart J. 2021 Feb 7. pii: S0002-8703(21)00032.
    PubMed     Abstract available

  67. BROPHY TJ, Warsavage TJ, Hebbe AL, Plomondon ME, et al
    Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program.
    Am Heart J. 2021 Feb 7. pii: S0002-8703(21)00034.
    PubMed     Abstract available

    January 2021
  68. SAWANO M, Spertus JA, Masoudi FA, Rumsfeld JS, et al
    Bleeding Avoidance Strategies and Percutaneous Coronary Intervention Outcomes: A Ten-year Observation from a Japanese Multicenter Registry: Post-PCI Bleeding Avoidance and Outcomes.
    Am Heart J. 2021 Jan 17. pii: S0002-8703(21)00014.
    PubMed     Abstract available

  69. GE Z, Kan J, Gao XF, Kong XQ, et al
    Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomized and multicenter DKCRUSH VIII trial.
    Am Heart J. 2021 Jan 16. pii: S0002-8703(21)00015.
    PubMed     Abstract available

  70. ZHAO Y, Sivaswamy A, Lee MK, Izadnegahdar M, et al
    A Feasibility Study for CODE-MI: High-Sensitivity Cardiac Troponin - Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women.
    Am Heart J. 2021 Jan 15. pii: S0002-8703(21)00012.
    PubMed     Abstract available

  71. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available

  72. THIELE H, Freund A, Gimenez MR, de Waha-Thiele S, et al
    Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial.
    Am Heart J. 2021 Jan 8. pii: S0002-8703(21)00004.
    PubMed     Abstract available

  73. MARBACH JA, Wells G, Santo PD, So D, et al
    Acute Kidney Injury after Radial or Femoral Artery Access in ST-Segment Elevation Myocardial Infarction: AKI-SAFARI.
    Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00001.
    PubMed     Abstract available

  74. FAGEL ND, Amoroso G, Vink MA, Slagboom T, et al
    An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: the OPTIMA-2 randomized controlled trial.
    Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00003.
    PubMed     Abstract available

    December 2020
  75. MALIK AO, Amin A, Kennedy K, Qintar M, et al
    Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention.
    Am Heart J. 2020 Dec 23. pii: S0002-8703(20)30415.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.